Reaffirming financial guidance typically signals to investors that a company is on track to meet or exceed its financial targets, which can positively influence investor sentiment and potentially lead to an increase in stock price in the short term. For Collegium Pharmaceutical, this reaffirmation suggests operational stability and confidence in its revenue-generating capabilities, which are crucial factors for investors.